How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

RETA Insider Trading (Reata Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,552,998.10

Reata Pharmaceuticals Insider Trading History Chart

Reata Pharmaceuticals Share Price & Price History

^$27.27

▲ +2 (7.91%)

As of 05/17/2022 02:14 PM ET

Days: 30 | 90 | 365

183 Pounds of Copper for Just ONE EV

From Investing Trends | Ad

To build just one electric vehicle (EV) engine requires 183 pounds of copper. Compare that to just 18 pounds required in a gas-powered car. That's 10 TIMES more copper. EVs are expected to increase 1,400% by 2030. More sources of copper are desperately needed to keep up with demand.

See Who Can Benefit from Huge Copper Demand.

Reata Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2021	Colin John Meyer	Insider	Sell	20,000	$144.05	$2,881,000.00	77,000
6/9/2021	Elaine Castellanos	CAO	Sell	8,454	$141.90	$1,199,622.60	16,092
6/7/2021	Elaine Castellanos	CAO	Sell	1,546	$146.75	$226,875.50	16,092
5/26/2021	Elaine Castellanos	CAO	Sell	10,000	$124.55	$1,245,500.00	24,546
11/11/2020	Michael D Wortley	Insider	Sell	51,429	$179.37	$9,224,819.73	51,429
11/10/2020	James Warren Huff	CEO	Sell	81,657	$175.01	$14,290,791.57
6/1/2020	Elaine Castellanos	CAO	Sell	2,000	$143.97	$287,940.00	17,146
3/2/2020	Elaine Castellanos	CAO	Sell	2,000	$194.32	$388,640.00	17,146
12/16/2019	Jason Douglas Wilson	VP	Sell	10,000	$203.26	$2,032,600.00	17,350
12/2/2019	Elaine Castellanos	CAO	Sell	2,000	$194.24	$388,480.00	17,146
11/18/2019	James W Traweek Jr	Major Shareholder	Buy	40,218	$183.00	$7,359,894.00	35
10/28/2019	Elaine Castellanos	CAO	Sell	4,000	$200.00	$800,000.00	19,146
10/25/2019	Elaine Castellanos	CAO	Sell	2,000	$190.00	$380,000.00	15,146
10/18/2019	Elaine Castellanos	Insider	Sell	2,000	$170.00	$340,000.00	13,933
10/17/2019	Jason Douglas Wilson	VP	Sell	10,000	$170.00	$1,700,000.00	17,350
10/14/2019	Elaine Castellanos	Insider	Sell	3,000	$105.00	$315,000.00	11,933
10/14/2019	Jason Douglas Wilson	VP	Sell	15,000	$100.00	$1,500,000.00	22,350
9/27/2019	James Warren Huff	CEO	Sell	63,000	$86.61	$5,456,430.00	164,157
9/6/2019	Elaine Castellanos	Insider	Sell	2,000	$85.00	$170,000.00	4,138
8/15/2019	Jason Douglas Wilson	CFO	Sell	4,000	$72.68	$290,720.00
7/15/2019	Jason Douglas Wilson	CFO	Sell	4,000	$84.64	$338,560.00	4,000
6/17/2019	Jason Douglas Wilson	CFO	Sell	4,000	$83.54	$334,160.00	4,000
6/3/2019	Elaine Castellanos	Insider	Sell	2,000	$85.20	$170,400.00	4,138

"The Most Critical Metal for Global Economies"

From Investing Trends | Ad

The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year.

Find Out How This Is Good News

SEC Filings (Institutional Ownership Changes) for Reata Pharmaceuticals (NASDAQ:RETA)

73.55% of Reata Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Reata Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/17/2022	Royal Bank of Canada	1,708	$56K	0.0%	-69.5%	0.005%
5/17/2022	Eaton Vance Management	27,801	$0.91M	0.0%	+77.7%	0.076%
5/17/2022	Ensign Peak Advisors Inc	21,427	$0.70M	0.0%	+225.6%	0.059%
5/16/2022	California State Teachers Retirement System	34,588	$1.13M	0.0%	-7.7%	0.095%
5/16/2022	Goldman Sachs Group Inc.	107,357	$3.52M	0.0%	-90.9%	0.295%
5/16/2022	PDT Partners LLC	10,357	$0.34M	0.0%	N/A	0.028%
5/16/2022	Wellington Management Group LLP	4,396,539	$144.03M	0.0%	+3.4%	12.077%
5/16/2022	State Street Corp	668,018	$21.88M	0.0%	-0.1%	1.835%
5/16/2022	Engineers Gate Manager LP	26,724	$0.88M	0.0%	+6.4%	0.073%
5/16/2022	Graham Capital Management L.P.	64,137	$2.10M	0.1%	N/A	0.176%
5/16/2022	Invesco Ltd.	56,112	$1.84M	0.0%	-97.5%	0.154%
5/16/2022	UBS Group AG	1,799	$59K	0.0%	-49.4%	0.005%
5/13/2022	Northern Trust Corp	268,555	$8.80M	0.0%	-2.8%	0.738%
5/13/2022	Verition Fund Management LLC	83,158	$2.72M	0.0%	N/A	0.228%
5/13/2022	Charles Schwab Investment Management Inc.	200,153	$6.56M	0.0%	+3.4%	0.550%
5/13/2022	XTX Topco Ltd	9,679	$0.32M	0.1%	N/A	0.027%
5/13/2022	American International Group Inc.	13,631	$0.45M	0.0%	-6.6%	0.037%
5/13/2022	Vanguard Group Inc.	2,643,082	$86.59M	0.0%	+3.3%	7.261%
5/12/2022	Integral Health Asset Management LLC	35,000	$1.15M	0.3%	-66.0%	0.096%
5/12/2022	BlackRock Inc.	2,075,760	$68M	0.0%	-1.8%	5.702%
5/12/2022	Metropolitan Life Insurance Co NY	1,785	$58K	0.0%	-76.3%	0.005%
5/12/2022	MetLife Investment Management LLC	15,591	$0.51M	0.0%	+58.5%	0.043%
5/12/2022	Citigroup Inc.	8,462	$0.28M	0.0%	-27.3%	0.023%
5/11/2022	King Luther Capital Management Corp	68,534	$2.25M	0.0%	-12.6%	0.188%
5/11/2022	US Bancorp DE	1,824	$60K	0.0%	+930.5%	0.005%
5/11/2022	Bank of New York Mellon Corp	120,675	$3.95M	0.0%	+1.6%	0.331%
5/11/2022	JPMorgan Chase & Co.	28,162	$0.92M	0.0%	+18.5%	0.077%
5/11/2022	WINTON GROUP Ltd	16,328	$0.54M	0.0%	N/A	0.045%
5/10/2022	ProShare Advisors LLC	8,407	$0.28M	0.0%	-19.4%	0.023%
5/10/2022	TD Asset Management Inc.	13,450	$0.44M	0.0%	-62.0%	0.037%
5/9/2022	Swiss National Bank	63,300	$2.07M	0.0%	+7.5%	0.174%
5/6/2022	Quadrant Capital Group LLC	25,882	$0.85M	0.1%	+29.2%	0.071%
5/4/2022	Arizona State Retirement System	7,231	$0.24M	0.0%	N/A	0.020%
4/29/2022	Emerald Mutual Fund Advisers Trust	218,006	$7.14M	0.3%	+25.1%	0.599%
4/29/2022	Emerald Advisers LLC	270,846	$8.87M	0.3%	+51.4%	0.744%
4/29/2022	Nisa Investment Advisors LLC	17,389	$0.57M	0.0%	-4.9%	0.048%
4/28/2022	MADDEN SECURITIES Corp	23,768	$0.78M	0.4%	-39.5%	0.065%
4/28/2022	Keybank National Association OH	15,250	$0.50M	0.0%	N/A	0.042%
4/28/2022	DekaBank Deutsche Girozentrale	16,640	$0.51M	0.0%	+9.9%	0.046%
4/27/2022	KRS Capital Management LLC	28,141	$0.92M	1.0%	-14.3%	0.077%
4/26/2022	Hennion & Walsh Asset Management Inc.	48,183	$1.58M	0.1%	+13.3%	0.132%
4/20/2022	Eagle Global Advisors LLC	8,565	$0.28M	0.0%	-29.1%	0.024%
4/7/2022	Woodstock Corp	13,473	$0.44M	0.1%	-4.7%	0.037%
3/9/2022	Norges Bank	218,725	$5.77M	0.0%	N/A	0.601%
3/3/2022	Walleye Capital LLC	51,036	$1.35M	0.0%	N/A	0.140%
2/23/2022	Barclays PLC	60,891	$1.61M	0.0%	+136.9%	0.167%
2/23/2022	BlackRock Inc.	2,114,050	$55.75M	0.0%	-0.3%	5.809%
2/19/2022	Wells Fargo & Company MN	27,845	$0.73M	0.0%	+46.4%	0.077%
2/18/2022	GAM Holding AG	25,146	$0.66M	0.0%	-6.7%	0.069%
2/17/2022	Goldman Sachs Group Inc.	1,182,570	$31.18M	0.0%	+566.6%	3.250%
2/16/2022	Allianz Asset Management GmbH	9,030	$0.24M	0.0%	-18.1%	0.025%
2/16/2022	Ghost Tree Capital LLC	55,000	$1.45M	0.5%	N/A	0.151%
2/16/2022	Deutsche Bank AG	649,654	$17.13M	0.0%	+0.1%	1.785%
2/16/2022	California State Teachers Retirement System	37,468	$0.99M	0.0%	+2.2%	0.103%
2/16/2022	Parametric Portfolio Associates LLC	17,462	$0.46M	0.0%	-66.5%	0.048%
2/15/2022	Stifel Financial Corp	9,590	$0.25M	0.0%	-78.3%	0.026%
2/15/2022	Kennedy Capital Management Inc.	79,524	$2.10M	0.0%	+12.9%	0.219%
2/15/2022	King Luther Capital Management Corp	78,459	$2.07M	0.0%	-31.9%	0.216%
2/15/2022	Millennium Management LLC	608,951	$16.06M	0.0%	-3,969.5%	1.673%
2/15/2022	Cubist Systematic Strategies LLC	43,621	$1.15M	0.0%	+37.5%	0.120%
2/15/2022	Delos Wealth Advisors LLC	5,600	$0.15M	0.1%	-17.0%	0.015%
2/14/2022	Canada Pension Plan Investment Board	156,000	$4.11M	0.0%	N/A	0.429%
2/14/2022	Virtus ETF Advisers LLC	5,684	$0.15M	0.1%	+282.5%	0.016%
2/14/2022	Squarepoint Ops LLC	74,679	$1.97M	0.0%	+273.5%	0.205%
2/14/2022	Opaleye Management Inc.	330,000	$8.70M	1.8%	N/A	0.907%
2/14/2022	Long Focus Capital Management LLC	48,000	$1.27M	0.2%	N/A	0.132%
2/14/2022	Credit Suisse AG	26,960	$0.71M	0.0%	-2.8%	0.074%
2/14/2022	State Street Corp	668,614	$17.63M	0.0%	+7.2%	1.837%
2/14/2022	Goldman Sachs Group Inc.	1,182,570	$31.18M	0.0%	+566.6%	3.250%
2/14/2022	Nuveen Asset Management LLC	97,415	$2.57M	0.0%	-7.1%	0.268%
2/14/2022	Barclays PLC	60,891	$1.61M	0.0%	+136.9%	0.167%
2/14/2022	Rockefeller Capital Management L.P.	1,250	$32K	0.0%	-63.7%	0.003%
2/14/2022	Invesco Ltd.	2,280,409	$60.13M	0.0%	-33.7%	6.266%
2/11/2022	KRS Capital Management LLC	32,841	$0.87M	0.7%	N/A	0.090%
2/11/2022	Geode Capital Management LLC	462,581	$12.20M	0.0%	-3.2%	1.271%
2/11/2022	Charles Schwab Investment Management Inc.	193,627	$5.11M	0.0%	+1.6%	0.532%
2/11/2022	Ensign Peak Advisors Inc	6,580	$0.17M	0.0%	N/A	0.018%
2/11/2022	Allianz Asset Management GmbH	9,030	$0.24M	0.0%	-18.1%	0.025%
2/10/2022	JPMorgan Chase & Co.	23,764	$0.63M	0.0%	-8.7%	0.065%
2/10/2022	Qube Research & Technologies Ltd	17,810	$0.47M	0.0%	N/A	0.049%
2/10/2022	Capital Fund Management S.A.	14,453	$0.38M	0.0%	N/A	0.040%
2/10/2022	Rafferty Asset Management LLC	11,450	$0.30M	0.0%	+68.0%	0.031%
2/10/2022	Citigroup Inc.	11,637	$0.31M	0.0%	-57.1%	0.032%
2/10/2022	TD Asset Management Inc.	35,360	$0.93M	0.0%	+33.3%	0.097%
2/10/2022	Campbell & CO Investment Adviser LLC	9,400	$0.25M	0.1%	N/A	0.026%
2/10/2022	HighTower Advisors LLC	54,823	$1.45M	0.0%	-7.2%	0.151%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	20,842	$0.55M	0.0%	+137.0%	0.057%
2/10/2022	California Public Employees Retirement System	54,226	$1.43M	0.0%	-3.9%	0.149%
2/9/2022	BNP Paribas Arbitrage SA	34,442	$0.91M	0.0%	+56.8%	0.095%
2/9/2022	AlphaCrest Capital Management LLC	72,489	$1.91M	0.1%	+1,355.3%	0.199%
2/8/2022	Lee Financial Co	2,118	$56K	0.0%	-21.1%	0.006%
2/8/2022	Teachers Retirement System of The State of Kentucky	55,172	$1.46M	0.0%	+12.7%	0.152%
2/8/2022	Bank of America Corp DE	95,218	$2.51M	0.0%	+7.5%	0.262%
2/8/2022	State Board of Administration of Florida Retirement System	12,987	$0.34M	0.0%	-4.1%	0.036%
2/7/2022	Victory Capital Management Inc.	11,126	$0.29M	0.0%	-11.7%	0.031%
2/7/2022	SG Americas Securities LLC	4,981	$0.13M	0.0%	-63.3%	0.014%
2/7/2022	American Century Companies Inc.	67,071	$1.77M	0.0%	+3.4%	0.184%
2/3/2022	Nisa Investment Advisors LLC	18,278	$0.51M	0.0%	+945.1%	0.050%
2/2/2022	Duality Advisers LP	123,844	$3.27M	0.4%	N/A	0.340%
2/2/2022	Emerald Mutual Fund Advisers Trust	174,316	$4.60M	0.2%	-37.9%	0.479%

Data available starting January 2016

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone that is Phase II clinical trial to treat Friedreich's ataxia; and conduct Phase 2 study for various form of CKD, such as IgA nephropathy, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and RTA 1701 for the potential treatment of a range of autoimmune, inflammatory, and fibrotic diseases. In addition, the company offers bardoxolone for the treatment of autosomal dominant polycystic kidney disease. Further, it has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; and AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.

Today's Range

Now: $27.27

$26.10

$28.83

50 Day Range

MA: $31.36

$20.71

$39.60

52 Week Range

Now: $27.27

$20.24

$153.41

Volume

18,190 shs

Average Volume

526,808 shs

Market Capitalization

$992.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Reata Pharmaceuticals?: Reata Pharmaceuticals' top insider investors include:
Colin John Meyer (Insider)
Michael D Wortley (Insider)
Elaine Castellanos (CAO)
James Warren Huff (CEO)
Learn More about top insider investors at Reata Pharmaceuticals.
Who are the major institutional investors of Reata Pharmaceuticals?: Reata Pharmaceuticals' top institutional investors include:
Wellington Management Group LLP — 12.08%
Vanguard Group Inc. — 7.26%
BlackRock Inc. — 5.70%
State Street Corp — 1.84%
Emerald Advisers LLC — 0.74%
Northern Trust Corp — 0.74%
Learn More about top institutional investors of Reata Pharmaceuticals stock.
Which institutional investors are selling Reata Pharmaceuticals stock?: Within the previous quarter, RETA stock was sold by these institutional investors:
Invesco Ltd.
Goldman Sachs Group Inc.
Integral Health Asset Management LLC
BlackRock Inc.
TD Asset Management Inc.
MADDEN SECURITIES Corp
King Luther Capital Management Corp
Northern Trust Corp
In the previous year, company insiders that have sold Reata Pharmaceuticals company stock include:
Colin John Meyer (Insider)
Michael D Wortley (Insider)
Learn More investors selling Reata Pharmaceuticals stock.
Which institutional investors are buying Reata Pharmaceuticals stock?: During the last quarter, RETA stock was acquired by institutional investors including:
Wellington Management Group LLP
Simplex Trading LLC
Emerald Advisers LLC
Vanguard Group Inc.
Verition Fund Management LLC
Graham Capital Management L.P.
Emerald Mutual Fund Advisers Trust
Cutler Group LP